MediWound (MDWD) Common Equity (2013 - 2025)

MediWound's Common Equity history runs 13 years deep, the most recent figure standing at $43.6 million for Q4 2025.

• On a quarterly basis, Common Equity rose 40.06% year-over-year to $43.6 million in Q4 2025; TTM through Dec 2025 was $43.6 million, a 40.06% increase from a year earlier, with the FY2025 full-year figure at $43.6 million, up 40.06% from the prior year.
• Common Equity retreated to $43.6 million in Q4 2025 per MDWD's latest filing, from $50.2 million in the prior quarter.
• Across five years, Common Equity topped out at $50.2 million in Q3 2025 and bottomed at -$4.6 million in Q4 2021.
• The 5-year median for Common Equity is $21.7 million (2024), against an average of $19.9 million.
• Across the five-year window, Common Equity plunged 205.52% in 2022 and soared 1895.77% in 2023, its largest moves.
• Year by year, Common Equity stood at -$4.6 million in 2021, then surged by 338.19% to $10.9 million in 2022, then jumped by 189.49% to $31.6 million in 2023, then slipped by 1.4% to $31.2 million in 2024, then jumped by 40.06% to $43.6 million in 2025.
• Per Business Quant, the three latest MDWD Common Equity figures stand at $43.6 million (Q4 2025), $50.2 million (Q3 2025), and $20.1 million (Q2 2025).